|
|
|
China novel drug EU clinical study project management
LCPS is the strategic partner with leading UK NHS teaching hospitals, research medical centres and build the good relationship with Australia leading hospitals to deliver the excellent international multi-centre clinical trial research study for Chinese pharmaceutical companies’ novel drug R&D. Our expert team will help Chinese pharmaceutical companies to manage the full phase of novel drug EU and Australia clinical research effectively to minimize the cost and maximize the research value from clinical trial regulatory approve to clinical trial phase I to IV and market authorization registration in EU and Australia.
What we do:
• Manage the streamlined process to obtain UK or Australia R&D
• Act as a single contact point for industry and research institutes.
• Handle commercial and non-commercial research projects phase I-IV
• Collate the national document set for multicentre research project applications
• Link and coordinate with regulatory bodies ,scientists, clinicians and hospitals to manage the project
• Actively manage the R&D permission and clinical trial project process to deliver on time
• Facilitate feasibility assessment across the different centres
• Monitor the progress of the clinical trial project and complete market authorization registration in EU and Australia |
